Your browser doesn't support javascript.
loading
Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
Gollapalli, Pavan; B S, Sharath; Rimac, Hrvoje; Patil, Prakash; Nalilu, Suchetha Kumari; Kandagalla, Shivanandha; Shetty, Praveenkumar.
  • Gollapalli P; Central Research Lab, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Deralakatte, Mangalore, India.
  • B S S; Department of Biotechnology and Bioinformatics, Kuvempu University, Shankaraghatta, Shivamogga, India.
  • Rimac H; Department of Medicinal Chemistry, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
  • Patil P; Laboratory of Computational Modelling of Drugs, Higher Medical and Biological School, South Ural State University, Chelyabinsk, Russia.
  • Nalilu SK; Central Research Lab, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Deralakatte, Mangalore, India.
  • Kandagalla S; Central Research Lab, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Deralakatte, Mangalore, India.
  • Shetty P; Laboratory of Computational Modelling of Drugs, Higher Medical and Biological School, South Ural State University, Chelyabinsk, Russia.
J Biomol Struct Dyn ; 40(6): 2701-2714, 2022 04.
Article en En | MEDLINE | ID: mdl-33146070

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Glicoproteína de la Espiga del Coronavirus / Enzima Convertidora de Angiotensina 2 / SARS-CoV-2 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Glicoproteína de la Espiga del Coronavirus / Enzima Convertidora de Angiotensina 2 / SARS-CoV-2 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article